Cytochrome P450 Enzymes: |
---|
GO Type | GO Category | Enriched GO Terms | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|---|
BP | GO:0008283; cell proliferation | GO:0008284; positive regulation of cell proliferation | 1.232E-06 | 1.412E-03 | ADRA2A, AKR1B1, BCL2, CSNK2A1, ELANE, ESR1, HIF1A, HPGD, MAPK1, MAPK14, PIM1, TSHR |
BP | GO:0008152; metabolic process | GO:0055114; oxidation-reduction process | 1.402E-06 | 1.527E-03 | AKR1B1, ALDH1A1, ALOX15, CYP2C9, CYP3A4, GAA, GFER, HPGD, HSD17B10, KDM4E, MAPK14, PGD |
BP | GO:0050896; response to stimulus | GO:1901700; response to oxygen-containing compound | 1.003E-05 | 6.827E-03 | AKR1B1, BCL2, BLM, CA3, CA9, CSNK2A1, ELANE, ESR1, HPGD, MAPK1, MAPK14, POLB, TSHR |
BP | GO:0009987; cellular process | GO:0033554; cellular response to stress | 1.333E-05 | 8.750E-03 | AKR1B1, ALOX15, BCL2, BLM, CA2, CA9, HIF1A, LMNA, MAPK1, MAPK14, MAPT, POLB, RECQL, TDP1 |
BP | GO:0051179; localization | GO:0015701; bicarbonate transport | 4.687E-20 | 5.103E-16 | CA1, CA12, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9 |
BP | GO:0008152; metabolic process | GO:0006730; one-carbon metabolic process | 7.983E-19 | 3.476E-15 | CA1, CA12, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9 |
CC | GO:0016020; membrane | GO:0016323; basolateral plasma membrane | 1.726E-08 | 3.132E-05 | ADRA2A, CA2, CA4, CA9, HPGD, SLCO1B1, SLCO1B3, TSHR |
MF | GO:0005488; binding | GO:0008270; zinc ion binding | 5.818E-08 | 9.048E-05 | BLM, CA1, CA12, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9, ESR1, ESR2 |
MF | GO:0003824; catalytic activity | GO:0004089; carbonate dehydratase activity | 8.778E-27 | 1.911E-22 | CA1, CA12, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9 |
MF | GO:0060089; molecular transducer activity | GO:0038052; RNA polymerase II transcription factor activity, estrogen-activated sequence-specific DNA binding | 6.047E-06 | 4.540E-03 | ESR1, ESR2 |
Pathway ID | Pathway Name | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|
hsa00052 | Galactose metabolism_Homo sapiens_hsa00052 | 2.351E-03 | 2.123E-02 | GAA; AKR1B1 |
hsa00590 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 9.732E-03 | 4.028E-02 | CYP2C9; ALOX15 |
hsa00591 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 4.537E-05 | 1.690E-03 | CYP2C9; ALOX15; CYP3A4 |
hsa00830 | Retinol metabolism_Homo sapiens_hsa00830 | 5.105E-04 | 9.238E-03 | CYP2C9; ALDH1A1; CYP3A4 |
hsa00910 | Nitrogen metabolism_Homo sapiens_hsa00910 | 5.410E-26 | 8.061E-24 | CA12; CA1; CA3; CA5B; CA2; CA5A; CA4; CA7; CA6; CA9; CA14 |
hsa00980 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.330E-02 | 4.404E-02 | CYP2C9; CYP3A4 |
hsa00982 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.195E-02 | 4.371E-02 | CYP2C9; CYP3A4 |
hsa01100 | Metabolic pathways_Homo sapiens_hsa01100 | 2.443E-03 | 2.123E-02 | CYP2C9; FUT7; GAA; ALOX15; ALDH1A1; AKR1B1; PGD; CYP3A4; HSD17B10 |
hsa04015 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 1.413E-02 | 4.480E-02 | MAPK1; MAPK14; MET |
hsa04022 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 7.510E-03 | 4.028E-02 | MAPK1; ADRA2C; ADRA2A |
ICD10 Disease Category | Disease Name | ICD10 Code | Linked Targets |
---|---|---|---|
A00-B99: Certain infectious and parasitic diseases | Helminth infection | A00-B99 | ACHE |
A00-B99: Certain infectious and parasitic diseases | Pediculus humanus capitis | B85.0 | ACHE |
A00-B99: Certain infectious and parasitic diseases | Bacterial infections | A00-B99 | CYP2C9 |
A00-B99: Certain infectious and parasitic diseases | Septic shock | A41.9 | ELANE |
A00-B99: Certain infectious and parasitic diseases | Trematode infection | B66.9 | ESR1 |
C00-D49: Neoplasms | Non-small cell lung cancer | C33-C34 | MET |
C00-D49: Neoplasms | Inflammatory disease | C11, C44, K75.9, M00-M25 | ELANE; MAPK14 |
C00-D49: Neoplasms | Lymphoma | C81-C86 | BCL2; HIF1A; CA9 |
C00-D49: Neoplasms | Hepatocellular carcinoma | C22.0 | MET |
C00-D49: Neoplasms | Advanced solid tumor | C00-C75, C7A, C7B | MET |